Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.34 (
lipoprotein lipase
)
7,025
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In chronic lymphocytic leukaemia (CLL),
lipoprotein lipase
(
LPL
) mRNA overexpression is an established poor prognostic marker, its function, however, is poorly understood. Measuring extracellular
LPL
enzymatic activity and protein, we found no difference between levels in CLL patients and those of controls, both before and after heparin treatment in vivo and in vitro. Investigating
LPL
knock down effects, we determined five potential downstream targets, of which one gene,
STXBP3
, reportedly is involved in fatty acid metabolism. While possibly reflecting an epigenetic switch towards an incorrect transcriptional program,
LPL
overexpression by itself does not appear to significantly influence CLL cell survival.
...
PMID:Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significance. 2347 42